Catalyst Wire Dossier Catalyst Wire Dossier

Tuznue

trastuzumab · Prestige Biopharma Belgium
Drug timelines are a Plus or Pro feature.

4 regulatory and trial events tracked for Tuznue, covering 2022-12-13 to 2026-08-18. Get the full timeline:

Most recent: EMA Authorised: Tuznue (trastuzumab) — Prestige Biopharma Belgium

See pricing